Daily monitoring of biomarkers of sepsis in complicated long-term icu-patients: Can it support treatment decisions?

Minerva Anestesiologica

Volumn 76, Issue 10, 2010, Pages 814-823

  Iapichino, G ^a   Marzorati, S ^a   Umbrello, M ^a   Baccalini, R ^a   Barassi, A ^c   Cainarca, M ^a   Pavini, F Colombo ^a   Mantovani, E ^a   Mauri, A ^a   Moroni, B ^a   Noto, A ^a   Melzid'eril, G V ^c   Langer, M ^b  

^a SAN PAOLO HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

C reactive protein; Intensive care; Interleukin 6; Sepsis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN;

ADULT; AGED; ARTICLE; CHRONIC PATIENT; CLINICAL EVALUATION; CONTROLLED STUDY; CRITICAL ILLNESS; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT ASSESSMENT; PATIENT CODING; PATIENT MONITORING; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL ILLNESS; DECISION MAKING; DIAGNOSIS, DIFFERENTIAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS; SHOCK, SEPTIC; SINGLE-BLIND METHOD; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 78149236263     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bone RC, Balk RA, Cerra FB, Dellinger R P, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
2. Levy MM, Fink M P, Marshall JC, Abraham E, Angus D, Cook D et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.
3. Dellinger R P, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008;34:17-60.
4. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006;34:2596-602.
5. Shehabi Y, Seppelt I. Pro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Crit Care 2008;12:211.
6. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008;36:941-52.
7. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7.
8. Dandona P, Nix D, Wilson M F, Aljada A, Love J, Assicot M et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-8.
9. Mokart D, Merlin M, Sannini A, Brun J P, Delpero JR, Houvenaeghel G et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005;94:767-73.
10. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003;31:1737-41.
11. Castelli G P, Pognani C, Cita M, Stuani A, Sgarbi L, Paladini R. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 2006;72:69-80.
12. Castelli G P, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004;8:R234-42.
13. Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006;97:503-8.
14. Rey C, Los Arcos M, Concha A, Medina A, Prieto S, Martinez P et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med 2007;33:477-84.
15. Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA et al. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 2007;142:134-42.
16. Iapichino G, Mistraletti G, Corbella D, Bassi G, Borotto E, Miranda DR et al. Scoring system for the selection of high-risk patients in the intensive care unit. Crit Care Med 2006;34:1039-43.
17. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63.
18. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.
19. Molnar Z, Bogar L. Let's go dynamic with procalcitonin! Crit Care Med 2006;34:2687-8.
20. Meisner M, Adina H, Schmidt J. Correlation of procalci-tonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006; 10:R1.
21. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999;3: 45-50.
22. Celebi S, Koner O, Menda F, Balci H, Hatemi A, Korkut K et al. Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery. Intensive Care Med 2006;32:881-7.
23. Clec'h C, Fosse J P, Karoubi P, Vincent F, Chouahi I, Hamza L et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006;34:102-7.
24. Marshall JC, Reinhart K. Biomarkers of sepsis. Crit Care Med 2009;37:2290-8.
25. Langer M, Haeusler EA. Ventilator associated pneumonia (VAP): an impossible diagnosis? Call for a pragmatic approach. Minerva Anestesiol 2009;75:584-90.
26. Charles PE, Ladoire S, Snauwaert A, Prin S, Aho S, Pechinot A et al. Impact of previous sepsis on the accuracy of procal-citonin for the early diagnosis of blood stream infection in critically ill patients. BMC Infect Dis 2008;8:163.
27. Hochreiter M, Kohler T, Schweiger AM, Keck FS, Bein B, von Spiegel T et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 2009;13:R83.